607 related articles for article (PubMed ID: 22732773)
1. Advances in understanding the molecular basis of frontotemporal dementia.
Rademakers R; Neumann M; Mackenzie IR
Nat Rev Neurol; 2012 Aug; 8(8):423-34. PubMed ID: 22732773
[TBL] [Abstract][Full Text] [Related]
2. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
[TBL] [Abstract][Full Text] [Related]
3. The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.
Gascon E; Gao FB
J Neurogenet; 2014; 28(1-2):30-40. PubMed ID: 24506814
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of ALS and FTD: implications for translational studies.
Liščić RM
Arh Hig Rada Toksikol; 2015 Dec; 66(4):285-90. PubMed ID: 26751860
[TBL] [Abstract][Full Text] [Related]
5. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.
Root J; Merino P; Nuckols A; Johnson M; Kukar T
Neurobiol Dis; 2021 Jul; 154():105360. PubMed ID: 33812000
[TBL] [Abstract][Full Text] [Related]
6. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.
Hsiung GY; DeJesus-Hernandez M; Feldman HH; Sengdy P; Bouchard-Kerr P; Dwosh E; Butler R; Leung B; Fok A; Rutherford NJ; Baker M; Rademakers R; Mackenzie IR
Brain; 2012 Mar; 135(Pt 3):709-22. PubMed ID: 22344582
[TBL] [Abstract][Full Text] [Related]
7. C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts.
Dobson-Stone C; Hallupp M; Bartley L; Shepherd CE; Halliday GM; Schofield PR; Hodges JR; Kwok JB
Neurology; 2012 Sep; 79(10):995-1001. PubMed ID: 22875086
[TBL] [Abstract][Full Text] [Related]
8. A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain.
Umoh ME; Dammer EB; Dai J; Duong DM; Lah JJ; Levey AI; Gearing M; Glass JD; Seyfried NT
EMBO Mol Med; 2018 Jan; 10(1):48-62. PubMed ID: 29191947
[TBL] [Abstract][Full Text] [Related]
9. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.
Simón-Sánchez J; Dopper EG; Cohn-Hokke PE; Hukema RK; Nicolaou N; Seelaar H; de Graaf JR; de Koning I; van Schoor NM; Deeg DJ; Smits M; Raaphorst J; van den Berg LH; Schelhaas HJ; De Die-Smulders CE; Majoor-Krakauer D; Rozemuller AJ; Willemsen R; Pijnenburg YA; Heutink P; van Swieten JC
Brain; 2012 Mar; 135(Pt 3):723-35. PubMed ID: 22300876
[TBL] [Abstract][Full Text] [Related]
10. Tale of two diseases: amyotrophic lateral sclerosis and frontotemporal dementia.
Verma A
Neurol India; 2014; 62(4):347-51. PubMed ID: 25237937
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p.
Stewart H; Rutherford NJ; Briemberg H; Krieger C; Cashman N; Fabros M; Baker M; Fok A; DeJesus-Hernandez M; Eisen A; Rademakers R; Mackenzie IR
Acta Neuropathol; 2012 Mar; 123(3):409-17. PubMed ID: 22228244
[TBL] [Abstract][Full Text] [Related]
12. C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis.
Diekstra FP; Van Deerlin VM; van Swieten JC; Al-Chalabi A; Ludolph AC; Weishaupt JH; Hardiman O; Landers JE; Brown RH; van Es MA; Pasterkamp RJ; Koppers M; Andersen PM; Estrada K; Rivadeneira F; Hofman A; Uitterlinden AG; van Damme P; Melki J; Meininger V; Shatunov A; Shaw CE; Leigh PN; Shaw PJ; Morrison KE; Fogh I; Chiò A; Traynor BJ; Czell D; Weber M; Heutink P; de Bakker PI; Silani V; Robberecht W; van den Berg LH; Veldink JH
Ann Neurol; 2014 Jul; 76(1):120-33. PubMed ID: 24931836
[TBL] [Abstract][Full Text] [Related]
13. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
Jovičić A; Paul JW; Gitler AD
J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
[TBL] [Abstract][Full Text] [Related]
14. Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the
Dols-Icardo O; García-Redondo A; Rojas-García R; Borrego-Hernández D; Illán-Gala I; Muñoz-Blanco JL; Rábano A; Cervera-Carles L; Juárez-Rufián A; Spataro N; De Luna N; Galán L; Cortes-Vicente E; Fortea J; Blesa R; Grau-Rivera O; Lleó A; Esteban-Pérez J; Gelpi E; Clarimón J
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):162-168. PubMed ID: 28889094
[TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanisms of Neurodegeneration Related to
Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G
Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737
[TBL] [Abstract][Full Text] [Related]
16. [Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)].
Tomiyama H
Brain Nerve; 2019 Nov; 71(11):1190-1208. PubMed ID: 31722305
[TBL] [Abstract][Full Text] [Related]
17. Screening for the C9ORF72 repeat expansion in a greek frontotemporal dementia cohort.
Kartanou C; Karadima G; Koutsis G; Breza M; Papageorgiou SG; Paraskevas GP; Kapaki E; Panas M
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):152-154. PubMed ID: 29166782
[TBL] [Abstract][Full Text] [Related]
18. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.
DeJesus-Hernandez M; Mackenzie IR; Boeve BF; Boxer AL; Baker M; Rutherford NJ; Nicholson AM; Finch NA; Flynn H; Adamson J; Kouri N; Wojtas A; Sengdy P; Hsiung GY; Karydas A; Seeley WW; Josephs KA; Coppola G; Geschwind DH; Wszolek ZK; Feldman H; Knopman DS; Petersen RC; Miller BL; Dickson DW; Boylan KB; Graff-Radford NR; Rademakers R
Neuron; 2011 Oct; 72(2):245-56. PubMed ID: 21944778
[TBL] [Abstract][Full Text] [Related]
19. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics.
Whitwell JL; Weigand SD; Boeve BF; Senjem ML; Gunter JL; DeJesus-Hernandez M; Rutherford NJ; Baker M; Knopman DS; Wszolek ZK; Parisi JE; Dickson DW; Petersen RC; Rademakers R; Jack CR; Josephs KA
Brain; 2012 Mar; 135(Pt 3):794-806. PubMed ID: 22366795
[TBL] [Abstract][Full Text] [Related]
20. Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature.
Giannoccaro MP; Bartoletti-Stella A; Piras S; Pession A; De Massis P; Oppi F; Stanzani-Maserati M; Pasini E; Baiardi S; Avoni P; Parchi P; Liguori R; Capellari S
J Neurol; 2017 Jul; 264(7):1426-1433. PubMed ID: 28620717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]